DHR Health Plans Mass Vaccination Clinic At Bert Ogden Arena

6,500 Doses of the Moderna Vaccine will be administered to qualifying recipients

Publisher's Picks
420

Translate to Spanish or other 102 languages!

Any questions can be directed to the DHR Covid Hotline at (956) 362-8800

Mega Doctor News

- Advertisement -

Edinburg –  DHR Health will provide vaccinations for eligible residents of the Rio Grande Valley this Tuesday, January 12th at the Bert Ogden Arena in Edinburg.

The 6,500 doses of the Moderna Vaccine will be administered to the following residents:

  • Tier 1a
    • Frontline Healthcare Workers
    • Residents of Long-term care facilities
  • Tier 1b
    • People aged 65 and older
    • People 18 years and older with at least one chronic medical condition, including
      • Cancer
      • Chronic Kidney Disease
      • COPD
      • Heart Conditions
      • Organ Transplantation
      • Obesity
      • Type 2 Diabetes
      • Pregnancy

Mandatory Check-In

- Advertisement -

Date:        Monday January 11, 2021

Time:        7:00 pm

Location:  HEB Park

    1616 S. Raul Longoria Rd, Edinburg, TX

- Advertisement -

     (overnight parking will be allowed)

Traffic will then be moved to the Bert Ogden Arena on Tuesday morning.

*Armbands will be given to the first 6500 eligible recipients in line with a consent form

Consent form must be filled out prior to arrival

Required consent forms can be downloaded at https://www.dshs.texas.gov/immunize/immtrac/forms.shtm

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Edinburg Rotary Club donates toys to children’s hospital
Next article
Dr. Hochman Announces Winners Of Nineteenth Annual Education Grants

More Articles

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -